Jedd D. Wolchok

Also affiliated with Cornell University, Swim Across America, Lander Institute, Parker Institute for Cancer Immunotherapy, Weill Cornell Medicine

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.5Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Papers

Driven by 65 papers — median percentile 78. Top paper: “Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma”.

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005

N/A

9.5DataRank · unranked

393 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0387

N/A

6.9DataRank · unranked

289 citations

Mercedes A. Duran Paez, Ninjit Dhanota, Walid K. Chatila, Sarah E. Bettigole, John Y. H. Kwon +36 more

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Journal of Clinical Oncology(2022)10.1200/jco.22.01763

N/A

5.4DataRank · unranked

446 citations

Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary I. Cohen, Thach‐Giao Truong +31 more

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010

N/A

3.9DataRank · unranked

100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of 89Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262485

N/A

3.7DataRank · unranked

124 citations

Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn +10 more

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Cancer Cell(2023)10.1016/j.ccell.2023.03.009

N/A

3.3DataRank · unranked

147 citations

Matthew D. Hellmann, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +28 more

Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

Nature Medicine(2021)10.1038/s41591-021-01388-5

N/A

2.7DataRank · unranked

113 citations

Rui Yang, Caner Aytekin, David Langlais, Mathieu Bourgey, Taushif Khan +50 more

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.010

N/A

2.2DataRank · unranked

82 citations

Meelad Amouzgar, Shannon M. Pfeiffer, Timothy R. Howes, Egmidio Medina, Michael J. Travers +14 more

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Nature Medicine(2024)10.1038/s41591-024-03040-4

N/A

2.1DataRank · unranked

107 citations

Minita Shah, Amanda Frydendahl, Daniel Halmos, Cole C. Khamnei, Nadia Øgaard +56 more

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

Nature Communications(2022)10.1038/s41467-022-29342-0

N/A

2.1DataRank · unranked

82 citations

Samuel A. Funt, Annie Borch, Kamilla Kjærgaard Munk, Anne-Mette Bjerregaard, James L. Reading +17 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2021)10.1016/j.ccell.2020.11.015

N/A

1.9DataRank · unranked

53 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Megan Wind-Rotolo +31 more

Eradicating micrometastases with immune checkpoint blockade: Strike while the iron is hot

Cancer Cell(2021)10.1016/j.ccell.2021.05.013

N/A

1.6DataRank · unranked

31 citations

Jedd D. Wolchok, Charlotte E. Ariyan, Yelena Y. Janjigian

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

The future of cancer immunotherapy: microenvironment-targeting combinations

Cell Research(2020)10.1038/s41422-020-0337-2

N/A

0.995DataRank · unranked

758 citations

Allison Betof Warner, Jedd D. Wolchok, Yonina R. Murciano‐Goroff

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

Nature Immunology(2020)10.1038/s41590-019-0589-5

N/A

0.966DataRank · unranked

624 citations

Fabien Franco, Yao-Chen Tsui, Xin Xie, Marcel P. Trefny, Roberta Zappasodi +15 more

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Molecular Therapy - Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.012

N/A

0.934DataRank · unranked

24 citations

Aris Angelis, Frederick R. Appelbaum, Nancy C. Andrews, Susan E. Bates, Arlene S. Bierman +33 more

Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0596

N/A

0.823DataRank · unranked

241 citations

Hira Rizvi, Jacklynn V. Egger, Isabel R. Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann +1 more

Future cancer research priorities in the USA: a Lancet Oncology Commission

The Lancet Oncology(2017)10.1016/s1470-2045(17)30698-8

N/A

0.801DataRank · unranked

208 citations

Chi Van Dang, David B. Agus, Brian M. Alexander, Kenneth C. Anderson, Alan Ashworth +64 more

Anatomic position determines oncogenic specificity in melanoma

Nature(2022)10.1038/s41586-022-04584-6

N/A

0.694DataRank · unranked

101 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

Nature(2022)10.1038/s41586-022-04696-z

N/A

0.663DataRank · unranked

82 citations

Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin +25 more

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3313

N/A

0.659DataRank · unranked

80 citations

Michael A. Postow, Bartosz Chmielowski, Ryan J. Sullivan, Amita Patnaik, Ezra E.W. Cohen +12 more

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0339

N/A

0.587DataRank · unranked

49 citations

Roberta Zappasodi, Hong Wang, Girish S. Naik, Takami Sato, Todd M. Bauer +13 more

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3936

N/A

0.571DataRank · unranked

44 citations

Susan J. Knox, Debra A. Goldman, Yuval Elhanati, Vikram Mavinkurve, Phillip Wong +20 more

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0.542DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

Regional and clonal T cell dynamics at single cell resolution in immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.27.461389

Top 38%

0.510DataRank

Top 38%6 citations

Andrew Chow, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +21 more

Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop

The Lancet Oncology(2023)10.1016/s1470-2045(22)00742-2

N/A

0.489DataRank · unranked

25 citations

Heiko Schöder, Elad Sharon, Jedd D. Wolchok, Michael V. Knopp, Richard L. Wahl +18 more

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1898105

N/A

0.489DataRank · unranked

25 citations

Hassane M. Zarour, Hussein A. Tawbi, John M. Kirkwood, Michael A. Postow, Philip Friedlander +11 more

OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs

The Journal of Experimental Medicine(2023)10.1084/jem.20221166

N/A

0.477DataRank · unranked

23 citations

Yi Wang, Shuaitong Liu, Shanza Baseer Tariq, Joseph M. Luna, Gregory Mazo +12 more

Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.17.476508

N/A

0.434DataRank · unranked

17 citations

Minita Shah, Nadia Øgaard, Cole C. Khamnei, Amanda Frydendahl, Aditya Deshpande +37 more

Anatomic position determines oncogenic specificity in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.14.383083

N/A

0.396DataRank · unranked

13 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.17.516904

N/A

0.345DataRank · unranked

9 citations

Adam J. Widman, Anushri Arora, Itai Rusinek, William F. Hooper, Rebecca L. Murray +30 more

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101818

N/A

0.241DataRank · unranked

4 citations

Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun, Ilinca Aricescu +17 more

CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.24.477554

N/A

0.240DataRank · unranked

3 citations

Fathema Uddin, Levi Mangarin, Hira Rizvi, Anton Dobrin, Sam E. Tischfield +31 more

Disparities in the use of checkpoint inhibitors and CAR T-cell therapy: A systematic review.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18541

N/A

0.165DataRank · unranked

2 citations

Adriana Espinosa, M. Ramos López, Burha Rasool, Taisha Gomez, Alexis Brown +6 more

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9559

N/A

0.165DataRank · unranked

2 citations

Yue Zheng, Michael B. Atkins, Bartosz Chmielowski, Ahmad A. Tarhini, Thach‐Giao Truong +14 more

Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9536

N/A

0.115DataRank · unranked

1 citations

Mark Klang, Michael A. Postow, Alexander N. Shoushtari, Ryan J. Sullivan, Jedd D. Wolchok +4 more

An ultrasmall core–shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments

Nature Nanotechnology(2025)10.1038/s41565-025-02083-z

N/A

0DataRank · unranked

14 citations

Li Zhang, Nabil A. Siddiqui, Nada Naguib, Feng Chen, Reethi Padmanabhan +12 more

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Nature Communications(2020)10.1038/s41467-020-17750-z

N/A

0DataRank · unranked

480 citations

Sadna Budhu, Jeremy H. Tchaicha, Chien‐Huan Weng, Mathieu Gigoux, Ivan Cohen +13 more

Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors

American Journal of Ophthalmology Case Reports(2020)10.1016/j.ajoc.2020.100799

N/A

0DataRank · unranked

16 citations

Korey Jaben, Jedd D. Wolchok, David H. Abramson, Jasmine H. Francis, Julia Canestraro

PD-L1 Blockade Therapy: Location, Location, Location

Cancer Cell(2020)10.1016/j.ccell.2020.10.017

N/A

0DataRank · unranked

15 citations

Jedd D. Wolchok, Chrysothemis C. Brown

Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.347

N/A

0DataRank · unranked

8 citations

Arnab Ghosh, Subhiksha Nandakumar, Joshua Armenia, Ying Z. Mazzu, Mohammad Atiq +6 more

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Cell(2021)10.1016/j.cell.2021.05.038

N/A

0DataRank · unranked

284 citations

Emma De Neef, James D. Thomas, Erich Sabio, Benoı̂t Rousseau, Mathieu Gigoux +30 more

Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors

Immunity(2021)10.1016/j.immuni.2021.05.003

N/A

0DataRank · unranked

764 citations

Omkar Chaudhary, Patricia Rodríguez-Morales, Xiaoli Sun, Dan Chen, Roberta Zappasodi +23 more

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Nature Medicine(2021)10.1038/s41591-021-01386-7

N/A

0DataRank · unranked

520 citations

Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson +55 more

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours

Nature(2021)10.1038/s41586-021-03326-4

N/A

0DataRank · unranked

395 citations

Inna Serganova, Ivan Cohen, Masatomo Maeda, Masahiro Shindo, Yasin Şenbabaoğlu +19 more

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003277

N/A

0DataRank · unranked

118 citations

David M. Faleck, Anusha Shirwaikar Thomas, Jessica Harris, Deepika Satish, Xuemei Wang +13 more

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4189

N/A

0DataRank · unranked

54 citations

Walid K. Chatila, Arshi Arora, Francisco Sánchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa +18 more

Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002569

N/A

0DataRank · unranked

24 citations

Shuaitong Liu, Peihong Dai, Ning Yang, Yi Wang, Rachel Giese +4 more

In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathology

Scientific Reports(2021)10.1038/s41598-021-01447-4

N/A

0DataRank · unranked

17 citations

Yuna Oh, Gary Peterson, Miguel Córdova, Cristián Navarrete‐Dechent, Melissa Gill +16 more

Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer

Communications Biology(2021)10.1038/s42003-021-02773-z

N/A

0DataRank · unranked

16 citations

Sadna Budhu, Kelly Fitzgerald, Rachel Giese, Adam O. Michel, Aliya Holland +7 more

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.36_suppl.356154

N/A

0DataRank · unranked

111 citations

Sandra J. Lee, Bartosz Chmielowski, Antoni Ribas, Ahmad A. Tarhini, Thach‐Giao Truong +9 more

Elucidating Mechanisms of Antitumor Immunity Mediated by Live Oncolytic Vaccinia and Heat-Inactivated Vaccinia

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.11.427912

N/A

0DataRank · unranked

4 citations

Peihong Dai, Shuaitong Liu, Ning Yang, Yi Wang, Rachel Giese +4 more

696 Single-cell RNA-seq reveals the critical roles of the STING- and MDA5-mediated cytosolic nucleic acid-sensing pathways as well as IFNAR/STAT2 signaling in recombinant MVA-induced antitumor immunity

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.696

N/A

0DataRank · unranked

0 citations

Gregory Mazo, Tuo Zhang, Ning Yang, Yi Wang, Adrian Y. Tan +7 more

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer

Nature(2022)10.1038/s41586-022-04735-9

N/A

0DataRank · unranked

203 citations

Zachary Sethna, Luis A. Rojas, Jayon Lihm, Barbara Bravi, Yuval Elhanati +28 more

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

The Journal of Experimental Medicine(2022)10.1084/jem.20212169

N/A

0DataRank · unranked

49 citations

Andrew Chow, Levi Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia +21 more

Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade

Journal of Clinical Investigation(2022)10.1172/jci148141

N/A

0DataRank · unranked

28 citations

Judith Michels, Riccardo Mezzadra, Divya Venkatesh, Lauren Dong, Ricardo Gomez +22 more

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant

npj Vaccines(2022)10.1038/s41541-022-00542-5

N/A

0DataRank · unranked

9 citations

Aitor Garcia, Cindy Meyer, Thomas Tuschl, Taha Merghoub, Jedd D. Wolchok +2 more

A phase II study of biomarker-driven early discontinuation of anti–PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps9591

N/A

0DataRank · unranked

4 citations

Sandra J. Lee, Michael B. Atkins, Terence Z. Wong, Jennifer L. Guerriero, Thomas U. Marron +8 more

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Nature(2023)10.1038/s41586-023-06063-y

N/A

0DataRank · unranked

1289 citations

Zachary Sethna, Kevin C. Soares, Cristina Olcese, Nan Pang, Erin Patterson +46 more

APR-246 increases tumor antigenicity independent of p53

Life Science Alliance(2023)10.26508/lsa.202301999

N/A

0DataRank · unranked

5 citations

Divya Venkatesh, Cailian Liu, Sadna Budhu, Hong Zhong, Mariam M. George +11 more

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps9603

N/A

0DataRank · unranked

7 citations

James Moon, Yana G. Najjar, Rupesh Kotecha, Vadim Spektor, Michael C. Wu +6 more

Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients

European Journal of Cancer(2024)10.1016/j.ejca.2024.115119

N/A

0DataRank · unranked

14 citations

G.V. Long, John O. Larkin, Jedd D. Wolchok, J.C. Hassel, D. Schadendorf +16 more

TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200862

N/A

0DataRank · unranked

9 citations

Daniel Hirschhorn, Meixian S Tang, Terence J. Purdon, Yacine Marouf, Alessandra Piersigilli +10 more

Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009609

N/A

0DataRank · unranked

1 citations

Allison L. Richards, Philip Friedlander, Jedd D. Wolchok, Andrea P. Moy, Alexander N. Shoushtari +1 more

Jedd D. Wolchok

Indexed papers

Top data-sharing exemplar

Papers